Company / Capital Expenditures
Bionano Genomics, Inc. Capital Expenditures History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
-
FY2020
5-year range
-
FY2018-FY2020
Trend
-100.0%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $331,716 to $0 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, capital expenditures decreased 100.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0 | -100.0% |
| FY2019 | $61.1K | -81.6% |
| FY2018 | $331.7K | - |
As of FY2020 · SEC Form 10-K · Last checked Jun 22, 2026